Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1

Interventions

Rituximab 2Lenalidomide 2umbralisib 1ublituximab 1tisagenlecleucel 1tazemetostat 1tafasitamab 1selinexor 1prednisolone phosphate 1prednisolone acetate 1polatuzumab vedotin 1Vincristine 1Prednisone 1Prednisolone 1Methylprednisolone 1Doxorubicin 1Cyclophosphamide 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1Appointments and Schedules 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Lymphoma, Large B-Cell, Diffuse × prednisolone acetate × Clear all
NCT01897571 2024-03-26

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Ipsen

Phase 1/2 Completed
400 enrolled 22 charts 1 FDA
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡